13F HOLDINGS REPORT
Affinity Asset Advisors, LLC
Quarter ended Q3 2023 · Filed August 14, 2023 · Accession 0001387131-23-009765
Total Value
$286.8M
Positions
71
Other Managers
0
Confidential Omitted
No
Holdings (71)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | MADRIGAL PHARMACEUTICALS INC | MDGL | 92,500 | $21.4M | 7.45% |
| 2 | CEREVEL THERAPEUTICS HLDNG I | 15678U128 | 550,000 | $17.5M | 6.10% |
| 3 | ESTABLISHMENT LABS HLDGS INC | ESTA | 211,608 | $14.5M | 5.06% |
| 4 | CHINOOK THERAPEUTICS INC | 16961L106 | 321,017 | $12.3M | 4.30% |
| 5 | MADRIGAL PHARMACEUTICALS INC | MDGL | 53,100 | $12.3M | 4.28% |
| 6 | TEVA PHARMACEUTICAL INDS LTD | 881624209 | 1,600,000 | $12.0M | 4.20% |
| 7 | MORPHIC HLDG INC | 61775R105 | 201,887 | $11.6M | 4.04% |
| 8 | CYMABAY THERAPEUTICS INC | 23257D103 | 1,050,118 | $11.5M | 4.01% |
| 9 | BIOGEN INC | BIIB | 40,000 | $11.4M | 3.97% |
| 10 | KURA ONCOLOGY INC | KURA | 910,317 | $9.6M | 3.36% |
| 11 | VERONA PHARMA PLC | 925050106 | 447,667 | $9.5M | 3.30% |
| 12 | BRIDGEBIO PHARMA INC | BBIO | 12,000,000 | $9.5M | 3.30% |
| 13 | ARCELLX INC | ACLX | 226,275 | $7.2M | 2.49% |
| 14 | PROTHENA CORP PLC | PRTA | 100,000 | $6.8M | 2.38% |
| 15 | BRIDGEBIO PHARMA INC | BBIO | 376,000 | $6.5M | 2.25% |
| 16 | VIKING THERAPEUTICS INC | VKTX | 350,000 | $5.7M | 1.98% |
| 17 | CENTESSA PHARMACEUTICALS PLC | CNTA | 900,723 | $5.6M | 1.94% |
| 18 | ASTRIA THERAPEUTICS INC | 04635X102 | 650,875 | $5.4M | 1.89% |
| 19 | ASCENDIS PHARMA A S | ASND | 57,760 | $5.2M | 1.80% |
| 20 | IMMUNOVANT INC | IMVT | 260,000 | $4.9M | 1.72% |
| 21 | VIKING THERAPEUTICS INC | VKTX | 300,000 | $4.9M | 1.70% |
| 22 | ASTRAZENECA PLC | AZN | 60,000 | $4.3M | 1.50% |
| 23 | INOZYME PHARMA INC | 45790W108 | 751,796 | $4.2M | 1.46% |
| 24 | CYTOKINETICS INC | CYTK | 125,148 | $4.1M | 1.42% |
| 25 | AUTOLUS THERAPEUTICS PLC | AUTL | 1,589,017 | $3.8M | 1.32% |
| 26 | IMMATICS N.V | IMTX | 300,000 | $3.5M | 1.21% |
| 27 | ESPERION THERAPEUTICS INC NE | ESPR | 6,925,000 | $3.4M | 1.20% |
| 28 | SPRINGWORKS THERAPEUTICS INC | 85205L107 | 130,000 | $3.4M | 1.19% |
| 29 | VENTYX BIOSCIENCES INC | 92332V107 | 100,696 | $3.3M | 1.15% |
| 30 | VIRIDIAN THERAPEUTICS INC | VRDN | 130,400 | $3.1M | 1.08% |
| 31 | REATA PHARMACEUTICALS INC | 75615P103 | 29,105 | $3.0M | 1.03% |
| 32 | CELLDEX THERAPEUTICS INC NEW | CLDX | 87,031 | $3.0M | 1.03% |
| 33 | FIBROGEN INC | 31572Q808 | 983,300 | $2.7M | 0.93% |
| 34 | FIBROGEN INC | 31572Q808 | 983,300 | $2.7M | 0.93% |
| 35 | XENON PHARMACEUTICALS INC | XENE | 60,376 | $2.3M | 0.81% |
| 36 | THESEUS PHARMACEUTICALS INC | 88369M101 | 240,244 | $2.2M | 0.78% |
| 37 | AEGLEA BIOTHERAPEUTICS INC | 00773J103 | 4,900,000 | $2.2M | 0.77% |
| 38 | VINCERX PHARMA INC | VNCE | 1,492,771 | $1.9M | 0.68% |
| 39 | LIANBIO | LIANY | 800,676 | $1.8M | 0.64% |
| 40 | CABALETTA BIO INC | CABA | 125,000 | $1.6M | 0.56% |
| 41 | KALVISTA PHARMACEUTICALS INC | KALV | 178,292 | $1.6M | 0.56% |
| 42 | PRECIGEN INC | PGEN | 1,500,000 | $1.5M | 0.53% |
| 43 | ADC THERAPEUTICS SA | ADCT | 600,000 | $1.3M | 0.45% |
| 44 | AADI BIOSCIENCE INC | WHWK | 187,675 | $1.3M | 0.45% |
| 45 | ALDEYRA THERAPEUTICS INC | ALDX | 150,000 | $1.3M | 0.44% |
| 46 | ALPINE IMMUNE SCIENCES INC | 02083G100 | 118,891 | $1.2M | 0.43% |
| 47 | NEWAMSTERDAM PHARMA COMPANY | NAMSW | 100,000 | $1.2M | 0.41% |
| 48 | ARAVIVE INC | 03890D108 | 861,200 | $1.1M | 0.38% |
| 49 | INFLARX NV | IFRX | 240,200 | $1.1M | 0.37% |
| 50 | MINERALYS THERAPEUTICS INC | MLYS | 62,500 | $1.1M | 0.37% |
| 51 | NURIX THERAPEUTICS INC | NRIX | 100,000 | $999,000 | 0.35% |
| 52 | BIOATLA INC | BCAB | 325,000 | $975,000 | 0.34% |
| 53 | FIBROGEN INC | 31572Q808 | 340,000 | $918,000 | 0.32% |
| 54 | APELLIS PHARMACEUTICALS INC | APLS | 10,000 | $911,000 | 0.32% |
| 55 | AXSOME THERAPEUTICS INC | AXSM | 12,500 | $898,250 | 0.31% |
| 56 | MILESTONE PHARMACEUTICALS IN | MIST | 300,068 | $855,194 | 0.30% |
| 57 | MIRUM PHARMACEUTICALS INC | MIRM | 30,000 | $776,100 | 0.27% |
| 58 | PUMA BIOTECHNOLOGY INC | PBYI | 202,349 | $714,292 | 0.25% |
| 59 | VAXCYTE INC | PCVX | 13,923 | $695,315 | 0.24% |
| 60 | JASPER THERAPEUTICS INC | JSPRW | 476,948 | $653,419 | 0.23% |
| 61 | IMMATICS N.V | IMTX | 187,204 | $632,750 | 0.22% |
| 62 | TALARIS THERAPEUTICS INC | 87410C104 | 200,000 | $608,000 | 0.21% |
| 63 | BRIDGEBIO PHARMA INC | BBIO | 35,133 | $604,288 | 0.21% |
| 64 | VIR BIOTECHNOLOGY INC | VIR | 20,000 | $490,600 | 0.17% |
| 65 | SPDR S&P 500 ETF TR | SPY | 18,087 | $488,256 | 0.17% |
| 66 | NUVATION BIO INC | NUVB | 250,000 | $450,000 | 0.16% |
| 67 | NLS PHARMACEUTICS LTD | H57830103 | 400,000 | $440,000 | 0.15% |
| 68 | CONTEXT THERAPEUTICS INC | CNTX | 267,574 | $428,118 | 0.15% |
| 69 | NEWAMSTERDAM PHARMA COMPANY | NAMSW | 37,000 | $77,330 | 0.03% |
| 70 | ARAVIVE INC | 03890D108 | 33,600 | $42,336 | 0.01% |
| 71 | ROCKET PHARMACEUTICALS INC | RCKTW | 75,000 | $13,913 | 0.00% |